Drug
Muraglitazar clinical trials
- studies test it
- 10
- open now
- 0
- in phase 3
- 10
- first study started
- 2002
How studies write it
Studies that test it under each name
Name
Studies by the year they started
10 studies that test it; most in 2003 (4)
| Year | Studies |
|---|---|
| 2002 | 2 |
| 2003 | 4 |
| 2004 | 2 |
| 2005 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 2
- Phase 3
- 10
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 10 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses muraglitazar is read from its arms, and is right about nine times in ten.
Testing it · 10
- An Investigational Drug Co-Administered With Insulin in Patients With Type 2 Diabetes (0478-065)TerminatedPhase 3Merck Sharp & Dohme LLCNCT00130806Written as MK0478 (muraglitazar)
- PPAR - Combination With MetforminCompletedPhase 3Bristol-Myers SquibbNCT00162240Written as Muraglitazar
- A Trial to Evaluate BMS-298585 as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic ControlCompletedPhase 3Bristol-Myers SquibbNCT00246987Written as Muraglitazar
- Efficacy and Safety of BMS-298585 Alone or in Combination With Pravastatin in Subjects With Mixed DyslipidemiaCompletedPhase 2/3Bristol-Myers SquibbNCT00245388Written as Muraglitazar
- Mechanism of Action and Efficacy of Muraglitazar in Type 2 DiabetesCompletedPhase 3Bristol-Myers SquibbNCT00094991Written as Muraglitazar
- Study Comparing Muraglitazar With Glimepiride in Type 2 Diabetics Who Are Not Controlled With Metformin AloneCompletedPhase 3Bristol-Myers SquibbNCT00095030Written as muraglitazar
- Study of Muraglitazar Versus Pioglitazone in Type 2 DiabetesCompletedPhase 3Bristol-Myers SquibbNCT00106808Written as Muraglitazar
- PPAR-COMBO With SulfonylureaCompletedPhase 3Bristol-Myers SquibbNCT00162175Written as Muraglitazar
- A Study to Evaluate Combining Metformin With Muraglitazar or Pioglitazone in Type 2 DiabeticsCompletedPhase 3Bristol-Myers SquibbNCT00240370Written as Muraglitazar
- Dose Ranging Study With LT, Monotherapy, PPARCompletedPhase 2/3Bristol-Myers SquibbNCT00240383Written as Muraglitazar
Codes
What other systems call muraglitazar · ClinicalTrials.gg INT004772
- MeSH (NLM) C500085muraglitazarOne source NLM
- UNII (FDA) W1MKM70WQIMURAGLITAZARConfirmed FDA, NLM, Wikidata
- Wikidata Q6937233muraglitazarConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C75190MuraglitazarOne source FDA
- DrugBank DB06510One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C500085 | muraglitazar | One source NLM |
| UNII (FDA) | W1MKM70WQI | MURAGLITAZAR | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q6937233 | muraglitazar | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C75190 | Muraglitazar | One source FDA |
| DrugBank | DB06510 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.